Affiliated with a Castle Connolly Top Hospital
Who is Dr. Norton, Surgical Oncologist in Stanford, CA?
Dr. Jeffrey Norton, MD is a Surgical Oncologist, who primarily practices in Stanford, CA with 1 additional practice location. He is board certified. Dr. Norton graduated from State University of New York Upstate Medical University and completed his residency at Branch Nci. Dr. Norton is fluent in English, and is currently seeing new patients. Dr. Norton’s practice accepts Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Norton’s office at (650) 498-6606.
What are Areas of Expertise for Dr. Norton?
Dr. Jeffrey Norton, MD is a highly-rated, board-certified Surgical Oncologist known for expertly diagnosing, treating, and managing a wide array of related conditions and procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. Norton empowers patients to confidently navigate their health journey, specializing in Adrenal Cancer, Endocrine Surgery, Gastrointestinal Cancer & Surgery, Pancreatic Cancer, and comprehensive wellness support. Serving the Stanford, CA community, Dr. Norton is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. Norton go to medical school and complete their residency?
Fellowship: National Cancer Institute
Residency: Branch Nci | Duke University Medical Center
Medical School: State University of New York Upstate Medical University
Is Dr. Norton board certified as a Surgical Oncologist?
Yes, Dr. Jeffrey Norton, MD is board certified by the American Board of Surgery , American Board of Surgery since 1983
What languages does Dr. Norton speak?
Dr. Norton and their clinical team can communicate with patients in the following languages:
English
What conditions does a Surgical Oncologist like Dr. Norton typically treat?
As a Surgical Oncologist, Dr. Norton diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Norton. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Pancreatic Cancer
- Cancer of the pancreas
- Malignant neoplasm of pancreas
- Pancreatic adenocarcinoma
- Pancreas Cancer
- Malignant Pancreatic Tumor
- Pancreatic Carcinoma
ICD-10 Codes:
- C250: Malignant neoplasm of head of pancreas
- C259: Malignant neoplasm of pancreas, unspecified
What procedures does a Surgical Oncologist like Dr. Norton typically perform?
As a Surgical Oncologist, procedures performed by Dr. Jeffrey Norton may include:
- 3D Conformal Radiotherapy
- Adaptive Radiation Therapy (ART)
- Adrenalectomy
- Blood Thinning Therapy / Anticoagulation
- Blood Transfusion Consultation
- Blood Transfusion Follow Up
- Bone Excision
- Bone Grafting
Please contact Dr. Norton's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Norton accept my insurance?
Dr. Norton accepts most major insurance plans. Important: Please call our office at (650) 498-6606 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Norton accept in Stanford, CA?
Dr. Norton in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Medicare
View All Insurances
Where is Dr. Norton's office located?
Recognitions
Publications
Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy
, 2014
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
, 2013
Seventh Edition (2010) of the AJCC
, 2013
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk
Recurrent Duodel Stricture Secondary to Untreated Crohn's Disease
, 2012
Value of Surgery in Patients With Negative Imaging and Sporadic Zollinger-Ellison Syndrome
, 2012
Failure to comply with NCCN guidelines for the magement of pancreatic cancer compromises outcomes
, 2012
Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
, 2012
A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
, 2011
Surgical Magement of Neuroendocrine Tumors of the Gastrointestil Tract
, 2011
Ruptured Biliary Cystadenoma Maged by Angiographic Embolization and Interval Partial Hepatectomy
, 2011
Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma
, 2011
Comparison of Intensity-Modulated Radiotherapy
, 2010
Role of Factor VII in Correcting Dilutiol Coagulopathy
, 2010
Solid Pseudopapillary Tumor of the Pancreas: An Unexpected Finding After Minor Abdomil Trauma
, 2010
INTERFRACTIOL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION
, 2010
Surgical Magement of Zollinger-Ellison Syndrome; State of the Art
, 2009
Appendiceal Mucinous Neoplasms Clinicopathologic Study of 116 Cases With Alysis of Factors
, 2009
INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS
, 2008
Gemcitabine chemotherapy
, 2008
Hereditary diffuse gastric cancer: surgery, surveillance and unswered questions
, 2008
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)
, 2008
Prospective study of surgery for primary hyperparathyroidism
, 2008
Tissue effects after stereotactic body radiotherapy using cyberknife
, 2008
Role of surgery in Zollinger-Ellison syndrome
, 2007
CDH1 truncating mutations in the E-cadherin gene
, 2007
Surgery increases survival in patients with gastrinoma
, 2006
Surgery for primary pancreatic neuroendocrine tumors
, 2006
Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.
, 2006
Inhibition of host sigl transducer
, 2006
Phase II study to assess the efficacy of conventiolly fractioted radiotherapy followed by a
, 2005
Surgery and prognosis of duodel gastrinoma as a duodel neuroendocrine tumor
, 2005
Endocrine tumours of the gastrointestil tract. Surgical treatment of neuroendocrine metastases.
, 2005
A tiol comparison of surgical versus percutaneous draige of pancreatic pseudocysts: 1997-2001
, 2005
Resolved and unresolved controversies in the surgical magement of patients with Zollinger
, 2004
Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases
, 2004
Magement and outcome of patients with sporadic gastrinoma arising in the duodenum
, 2003
Possible primary lymph node gastrinoma: Occurrence, tural history
, 2003
Comparison of surgical results in patients with advanced
, 2001
Prognostic value of initial pasting serum gastrin levels in patients with Zollinger
, 2001
Surgery to cure the Zollinger-Ellison syndrome
, 1999
Alysis of factors associated with longterm
, 1998
Operative magement of islet-cell tumors arising in the head of the pancreas
, 1998
Prospective study of somatostatin receptor scintigraphy
, 1998
A prospective alysis of the frequency, location
, 1997
A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma
, 1996
Role of endogenous interferon gamma in murine tumor growth
, 1996
PLASMA PROINSULIN-LIKE COMPONENT IN INSULINOMA - A 25-YEAR EXPERIENCE
, 1995
LOCALIZATION OF INSULINOMAS TO REGIONS OF THE PANCREAS BY INTRAARTERIAL STIMULATION WITH CALCIUM
, 1995
LOCALIZATION AND OPERATIVE MAGEMENT OF UNDESCENDED PARATHYROID ADENOMAS IN PATIENTS
, 1994
SURGERY IN ZOLLINGER-ELLISON SYNDROME ALTERS THE TURAL-HISTORY OF GASTRINOMA
, 1994
CONTROVERSIES IN SURGICAL THERAPY FOR APUDOMAS
, 1993
USE OF INTRAOPERATIVE ULTRASONOGRAPHY TO LOCALIZE ISLET-CELL TUMORS
, 1993
INTRAARTERIAL CALCIUM STIMULATION TEST FOR DETECTION OF INSULINOMAS
, 1993
RECOMBINT INTERLEUKIN-1 RECEPTOR ANTAGONIST
, 1992
CURATIVE RESECTION IN ZOLLINGER-ELLISON SYNDROME - RESULTS OF A 10-YEAR PROSPECTIVE-STUDY
, 1992
LOCALIZATION AND SURGICAL-TREATMENT OF OCCULT INSULINOMAS
, 1990
UNDESCENDED PARATHYROID ADENOMA
, 1990
THE ROLE OF SURGERY IN THE MAGEMENT OF ISLET CELL TUMORS
, 1989
REVERSAL OF THE TOXIC EFFECTS OF CACHECTIN BY CONCURRENT INSULIN ADMINISTRATION
, 1989
LOCALIZATION AND RESECTION OF INSULINOMAS AND GASTRINOMAS
, 1988
INTRAOPERATIVE ULTRASONOGRAPHIC LOCALIZATION OF ISLET CELL TUMORS
, 1988
THE USE OF HIGH-RESOLUTION INTRAOPERATIVE ULTRASOUND TO LOCALIZE GASTRINOMAS
, 1987
THE USE OF HIGH-RESOLUTION ULTRASOUND TO LOCATE PARATHYROID TUMORS DURING REOPERATIONS FOR PRIMARY
, 1987
INFERIOR THYROID ARTERY ARISING FROM COMMON CAROTID-ARTERY WITH ABERRANT RIGHT SUBCLAVIAN ARTERY
, 1987
SELECTIVE VENOUS SAMPLING FOR GASTRIN TO LOCALIZE GASTRINOMAS - A PROSPECTIVE ASSESSMENT
, 1986
PROSPECTIVE-STUDY OF GASTRINOMA LOCALIZATION AND RESECTION IN PATIENTS WITH ZOLLINGER
, 1986
INTRAOPERATIVE ULTRASOUND AND REOPERATIVE PARATHYROID SURGERY - AN INITIAL EVALUATION
, 1986
DEMONSTRATION OF AN ANGIOGRAPHICALLY HYPOVASCULAR INSULINOMA WITH INTRAARTERIAL DYMIC CT
, 1985
INTRAOPERATIVE URIRY CYCLIC ADENOSINE
, 1984
HYPERFUNCTIONING CYSTIC PARATHYROID-GLANDS - CT AND SONOGRAPHIC FINDINGS
, 1984
PARATHYROID ASPIRATION DIRECTED BY ANGIOGRAPHY - AN ALTERTIVE TO VENOUS SAMPLING
, 1984
REMOVAL OF GASTRINOMAS FOR CONTROL OF ZOLLINGER-ELLISON SYNDROME
, 1984
DETECTION OF MEDIASTIL PARATHYROID-GLANDS BY NONSELECTIVE DIGITAL ARTERIOGRAPHY
, 1984
LOCALIZATION OF ISLET CELL TUMORS BY DYMIC CT - COMPARISON WITH PLAIN CT, ARTERIOGRAPHY
, 1984
LOCALIZATION AND RESECTION OF CLINICALLY IPPARENT MEDULLARY CARCINOMA OF THE THYROID
, 1980
Postoperative serum amylase predicts pancreatic fistula formation following pancreaticoduodenectomy
, 2014
Metabolomic-derived novel cyst fluid biomarkers for pancreatic cysts: glucose and kynurenine
, 2013
Preexisting antitumor immunity augments the antitumor effects of chemotherapy.
, 2013
Seventh Edition (2010) of the AJCC
, 2013
Hospital readmission after a pancreaticoduodenectomy: an emerging quality metric?
, 2013
Long-term Results of Adjuvant Imatinib Mesylate in Localized, High-Risk
Recurrent Duodenal Stricture Secondary to Untreated Crohn's Disease
, 2012
Value of Surgery in Patients With Negative Imaging and Sporadic Zollinger-Ellison Syndrome
, 2012
Failure to comply with NCCN guidelines for the management of pancreatic cancer compromises outcomes
, 2012
Pancreatic Neuroendocrine Tumors: Radiographic Calcifications Correlate with Grade and Metastasis
, 2012
Intensity-Modulated Radiotherapy for Pancreatic Adenocarcinoma
, 2012
A Prospective Study of Total Gastrectomy for CDH1-Positive Hereditary Diffuse Gastric Cancer
, 2011
Surgical Management of Neuroendocrine Tumors of the Gastrointestinal Tract
, 2011
Ruptured Biliary Cystadenoma Managed by Angiographic Embolization and Interval Partial Hepatectomy
, 2011
Pancreatic Endocrine Tumors With Major Vascular Abutment, Involvement
, 2011
Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma
, 2011
Supercharged Jejunum Flap for Total Esophageal Reconstruction
, 2011
Expression of p16(INK4A) But Not Hypoxia Markers or Poly Adenosine Diphosphate
, 2010
Comparison of Intensity-Modulated Radiotherapy
, 2010
Role of Factor VII in Correcting Dilutional Coagulopathy
, 2010
A NOVEL PRKAR1A MUTATION ASSOCIATED WITH PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE AND THE
, 2010
Solid Pseudopapillary Tumor of the Pancreas: An Unexpected Finding After Minor Abdominal Trauma
, 2010
INTERFRACTIONAL UNCERTAINTY IN THE TREATMENT OF PANCREATIC CANCER WITH RADIATION
, 2010
Surgical Management of Zollinger-Ellison Syndrome; State of the Art
, 2009
Appendiceal Mucinous Neoplasms Clinicopathologic Study of 116 Cases With Analysis of Factors
, 2009
Major Blood Vessel Reconstruction During Sarcoma Surgery
, 2009
The value of surgery for retroperitoneal sarcoma.
, 2009
INTRAOPERATIVE RADIATION THERAPY FOR LOCALLY ADVANCED AND RECURRENT SOFT-TISSUE SARCOMAS IN ADULTS
, 2008
Gemcitabine chemotherapy
, 2008
Hereditary diffuse gastric cancer - Implications of genetic testing for screening
, 2008
Hereditary diffuse gastric cancer: surgery, surveillance and unanswered questions
, 2008
Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1)
, 2008
Prospective study of surgery for primary hyperparathyroidism
, 2008
High predictive value of pancreatic protocol CT as the only preoperative staging
, 2008
Tissue effects after stereotactic body radiotherapy using cyberknife
, 2008
Role of surgery in Zollinger-Ellison syndrome
, 2007
CDH1 truncating mutations in the E-cadherin gene
, 2007
Surgery for gastrinoma.
, 2007
Surgery increases survival in patients with gastrinoma
, 2006
Lessons from Coley's Toxin
, 2006
Surgery for primary pancreatic neuroendocrine tumors
, 2006
Surgery for gastrinoma and insulinoma in multiple endocrine neoplasia type 1.
, 2006
Inhibition of host signal transducer
, 2006
Surgical treatment and prognosis of gastrinoma
, 2005
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a
, 2005
Surgery and prognosis of duodenal gastrinoma as a duodenal neuroendocrine tumor
, 2005
Computed tomography, endoscopic
, 2005
Endocrine tumours of the gastrointestinal tract. Surgical treatment of neuroendocrine metastases.
, 2005
A national comparison of surgical versus percutaneous drainage of pancreatic pseudocysts: 1997-2001
, 2005
Gastric carcinoid tumors in multiple endocrine neoplasia-1 patients with Zollinger
, 2004
Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison
, 2004
Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases
, 2004
Results of initial operation for hyperparathyroidism
, 2003
Management and outcome of patients with sporadic gastrinoma arising in the duodenum
, 2003
Possible primary lymph node gastrinoma: Occurrence, natural history
, 2003
Comparison of surgical results in patients with advanced
, 2001
Prognostic value of initial pasting serum gastrin levels in patients with Zollinger
, 2001
A high-resolution radiation hybrid map of the human genome draft sequence
, 2001
Results of heterotopic parathyroid autotransplantation: A 13-year experience
, 1999
Surgery to cure the Zollinger-Ellison syndrome
, 1999
Analysis of factors associated with longterm
, 1998
Operative management of islet-cell tumors arising in the head of the pancreas
, 1998
Surgical treatment of localized gastrinoma within the liver: A prospective study
, 1998
Prospective study of somatostatin receptor scintigraphy
, 1998
A prospective analysis of the frequency, location
, 1997
Is reoperation for gastrinoma excision indicated in Zollinger-Ellison syndrome?
, 1996
A prospective trial evaluating a standard approach to reoperation for missed parathyroid adenoma
, 1996
Role of endogenous interferon gamma in murine tumor growth
, 1996
PLASMA PROINSULIN-LIKE COMPONENT IN INSULINOMA - A 25-YEAR EXPERIENCE
, 1995
LOCALIZATION OF INSULINOMAS TO REGIONS OF THE PANCREAS BY INTRAARTERIAL STIMULATION WITH CALCIUM
, 1995
PALLIATIVE OPERATIONS FOR PATIENTS WITH UNRESECTABLE ENDOCRINE NEOPLASIA
, 1995
LOCALIZATION AND OPERATIVE MANAGEMENT OF UNDESCENDED PARATHYROID ADENOMAS IN PATIENTS WITH
, 1994
SURGERY IN ZOLLINGER-ELLISON SYNDROME ALTERS THE NATURAL-HISTORY OF GASTRINOMA
, 1994
CONTROVERSIES IN SURGICAL THERAPY FOR APUDOMAS
, 1993
USE OF INTRAOPERATIVE ULTRASONOGRAPHY TO LOCALIZE ISLET-CELL TUMORS
, 1993
INTRAARTERIAL CALCIUM STIMULATION TEST FOR DETECTION OF INSULINOMAS
, 1993
THE ROLE OF TUMOR-NECROSIS
, 1993
RECOMBINANT INTERLEUKIN-1 RECEPTOR ANTAGONIST
, 1992
CURATIVE RESECTION IN ZOLLINGER-ELLISON SYNDROME - RESULTS OF A 10-YEAR PROSPECTIVE-STUDY
, 1992
The use of intraoperative ultrasound during cancer surgery.
, 1992
RESULTS OF A PROSPECTIVE STRATEGY TO DIAGNOSE, LOCALIZE, AND RESECT INSULINOMAS
, 1991
INSULINOMAS - LOCALIZATION WITH SELECTIVE INTRAARTERIAL INJECTION OF CALCIUM
, 1991
LOCALIZATION AND SURGICAL-TREATMENT OF OCCULT INSULINOMAS
, 1990
UNDESCENDED PARATHYROID ADENOMA
, 1990
THE ROLE OF SURGERY IN THE MANAGEMENT OF ISLET CELL TUMORS
, 1989
REVERSAL OF THE TOXIC EFFECTS OF CACHECTIN BY CONCURRENT INSULIN ADMINISTRATION
, 1989
TOLERANCE TO TUMOR NECROSIS FACTOR
, 1989
LOCALIZATION AND RESECTION OF INSULINOMAS AND GASTRINOMAS
, 1988
INTRAOPERATIVE ULTRASONOGRAPHIC LOCALIZATION OF ISLET CELL TUMORS
, 1988
THE USE OF HIGH-RESOLUTION INTRAOPERATIVE ULTRASOUND TO LOCALIZE GASTRINOMAS
, 1987
THE USE OF HIGH-RESOLUTION ULTRASOUND TO LOCATE PARATHYROID TUMORS DURING REOPERATIONS FOR PRIMARY
, 1987
INFERIOR THYROID ARTERY ARISING FROM COMMON CAROTID-ARTERY WITH ABERRANT RIGHT SUBCLAVIAN ARTERY
, 1987
LOCALIZATION OF PARATHYROID ADENOMAS IN PATIENTS WHO HAVE UNDERGONE SURGERY .2. INVASIVE PROCEDURES
, 1987
LOCALIZATION OF PARATHYROID ADENOMAS IN PATIENTS WHO HAVE UNDERGONE SURGERY
, 1987
SELECTIVE VENOUS SAMPLING FOR GASTRIN TO LOCALIZE GASTRINOMAS - A PROSPECTIVE ASSESSMENT
, 1986
PROSPECTIVE-STUDY OF GASTRINOMA LOCALIZATION AND RESECTION IN PATIENTS WITH ZOLLINGER
, 1986
INTRAOPERATIVE ULTRASOUND AND REOPERATIVE PARATHYROID SURGERY - AN INITIAL EVALUATION
, 1986
DEMONSTRATION OF AN ANGIOGRAPHICALLY HYPOVASCULAR INSULINOMA WITH INTRAARTERIAL DYNAMIC CT
, 1985
PARATHYMIC PARATHYROID - CT, US, AND ANGIOGRAPHIC FINDINGS
, 1985
ULTRASONIC PARATHYROID LOCALIZATION IN PREVIOUSLY OPERATED PATIENTS
, 1984
INTRAOPERATIVE URINARY CYCLIC ADENOSINE
, 1984
HYPERFUNCTIONING CYSTIC PARATHYROID-GLANDS - CT AND SONOGRAPHIC FINDINGS
, 1984
PARATHYROID ASPIRATION DIRECTED BY ANGIOGRAPHY - AN ALTERNATIVE TO VENOUS SAMPLING
, 1984
REMOVAL OF GASTRINOMAS FOR CONTROL OF ZOLLINGER-ELLISON SYNDROME
, 1984
DETECTION OF MEDIASTINAL PARATHYROID-GLANDS BY NONSELECTIVE DIGITAL ARTERIOGRAPHY
, 1984
LOCALIZATION OF ISLET CELL TUMORS BY DYNAMIC CT - COMPARISON WITH PLAIN CT, ARTERIOGRAPHY
, 1984
WORK IN PROGRESS - ABNORMAL PARATHYROID
, 1983
ASPIRATION OF ENLARGED PARATHYROID-GLANDS FOR PARATHYROID-HORMONE ASSAY
, 1983
LOCALIZATION AND RESECTION OF CLINICALLY INAPPARENT MEDULLARY CARCINOMA OF THE THYROID
, 1980
What is Dr. Norton's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Norton's National Provider Identifier (NPI) number is 1255471371.
What common questions do patients ask about Dr. Norton?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Norton
What is Dr. Jeffrey Norton's specialty?
Dr. Norton is a Surgical Oncologist near Stanford, CA.
What does a Surgical Oncologist do?
A surgical oncologist is a highly qualified and trained surgeon with specialized expertise in the prevention, diagnosis, treatment, and rehabilitation of cancer patients. They have received additional training in a multidisciplinary approach and dedicate a significant portion of their practice to these areas, as well as to cancer research.
Is this Dr. Jeffrey Norton affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Norton is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Surgical Oncologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Surgical Oncologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Jeffrey Norton accepting new patients in Stanford, CA?
Yes, Dr. Jeffrey Norton is accepting new patients at this time.
Does Dr. Jeffrey Norton offer online booking?
Please contact Dr. Norton's office at (650) 498-6606 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Jeffrey Norton?
Please contact Dr. Norton's office at (650) 498-6606 for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Jeffrey Norton have?
Dr. Jeffrey Norton is certified by the American Board of Surgery.
Other Surgical Oncologist Near Stanford, CA
Surgeon
Accepting patients
Surgeon
Accepting patientsSurgeon
Accepting patients